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OBJECTIVES To investigate the occurrence of nocturnal ischemic events in patients with obstructive sleep
apnea syndrome (OSAS) and ischemic heart disease (IHD).
BACKGROUND Although previous reports documented nocturnal cardiac ischemic events among OSAS
patients, the exact association between obstructive apneas and ischemia is not yet clear. It is
also not known what differentiates between patients showing nocturnal ischemia and those
that do not.
METHODS Fifty-one sleep apnea patients (age 61.3 6 8.3) with IHD participated in the study (after
withdrawal of beta-adrenergic blocking agents and anti-anginotic treatment). All patients
underwent whole-night polysomnography including ambulatory blood pressure recordings
(30 min interval) and continuous Holter monitoring during sleep. A control group of 17
OSAS patients free from IHD were also similarly studied. Fifteen of the 51 patients were also
recorded under continuous positive airway pressure (CPAP).
RESULTS Nocturnal ST segment depression occurred in 10 patients (a total of 15 events, 182 min), of
whom six also had morning ischemia (06–08 am). Five additional patients had only morning
ischemia. No ischemic events occurred in the control group. Age, sleep efficiency, oxygen
desaturation, IHD severity and nocturnal-double product (DP) values were the main variables
that significantly differentiated between patients who had ischemic events during sleep and
those who did not. Nocturnal ischemia predominantly occurred during the rebreathing phase
of the obstructive apneas, and it is characterized by increased heart rate (HR) and DP values.
Treatment with continuous positive airway pressure significantly ameliorated the nocturnal
ST depression time from 78 min to 33 min (p , 0.001) as well as the maximal DP values
(14,137 6 2,827 vs. 12,083 6 2,933, p , 0.001).
CONCLUSIONS Exacerbation of ischemic events during sleep in OSAS may be explained by the combination
of increased myocardial oxygen consumption as indicated by increased DP values and
decreased oxygen supply due to oxygen desaturation with peak hemodynamic changes during
the rebreathing phase of the obstructive apnea. Treatment with CPAP ameliorated the
nocturnal ischemia. (J Am Coll Cardiol 1999;34:1744–9) © 1999 by the American College
of Cardiology
The relative risk for ischemic heart disease (IHD) among
snorers and obstructive sleep apnea syndrome patients
(OSAS) is 1.2 to 6.9 higher compared with the general
population (1–3). The combination of repetitive hypoxemic
events and sympathetic overstimulation in OSAS may
increase blood pressure and myocardial oxygen demand
(4,5). Considering impaired coronary reserve, it seems that
comorbidity of OSAS and IHD may expose these patients
to ischemic events during sleep. Recent studies investigating
nocturnal ischemia in OSAS have provided inconsistent
results (Table 1). Franklin et al. (6) demonstrated OSAS
among 9 of 10 ischemic patients who suffered from noctur-
nal angina pectoris. Scha¨fer et al. (7) found that 5 out of 14
OSAS 1 IHD patients had nocturnal ischemia and that
85.4% of the ischemic episodes were concomitant with
apneas and oxygen desaturation. Most of them occurred
during rapid eye movement (REM) sleep. Moreover, others
(8) demonstrated ST segment depression during sleep
without IHD. Hillman (3) reported that acute cardiac
ischemia was an infrequent finding among postmyocardial
infarction (MI) OSAS patients (16 patients) although he
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also reported that apnea hypopnea index (AHI) is an
independent risk factor for MI. Other studies also demon-
strated a lack of association between nocturnal hypoxemia
and cardiac ischemia (9–11).
In this study, we examined nocturnal ischemia among 51
OSAS 1 IHD patients and analyzed the association of
these events with the obstructive apneas before and during
continuous positive air pressure (CPAP) treatment.
METHODS
Patients. Fifty-one patients suffering from OSAS and
from IHD (age 61.3 6 8.3 yr) participated in the study. All
had clinical symptoms and positive ergometry for IHD
(mean functional capacity 2.06 6 0.76; Mets for ischemia:
8.08 6 2.18). Fifteen had coronary angiography, one with
four-vessel disease (VD), three with three-VD, seven with
two-VD and four with one-VD. Twenty-one patients had
hypertension, nine mild hyperlipidemia, five peptic disease,
four noninsulin diabetic mellitus, three chronic obstructive
lung disease and two had previously mild cerebral vascular
accident (CVA). Patients with IHD were selected for the
study according to a sleep questionnaire, which indicated a
high probability of OSAS. Patients with poorly controlled
heart failure, insomnia, wide QRS complex, nonsinus
rhythm and digoxin treatment were excluded. Patients
being treated with nitrates, calcium-antagonist, ACE-
inhibitors and beta-adrenergic blocking agents were weaned
gradually 72 h before the sleep study. Patients were under
medical supervision throughout the study, as was specified
in the informed consent form. A group of 17 OSAS patients
(age 47.4 6 10.9 years) free from IHD symptoms and
without ischemia at ergometry underwent the same study, as
a control group. The study for both groups was approved by
the appropriate Human Rights Committee.
Sleep study. All patients underwent whole night polysom-
nographic recordings which consisted of horizontal electro-
oculogram, submental electromyogram, 23 ECG (lead I,
V5), electroencephalogram (C3–A2), air flow (thermistor),
chest movements, bed movements and pulse oxymetry
(ear/finger tip). All channels were displayed on polygraph
(Nihon Kohden, EEG-4214, Japan) with a paper speed
Abbreviations and Acronyms
AHI 5 apnea hypopnea index
ANOVA 5 analysis of variance
BP 5 blood pressure
CPAP 5 continuous positive air pressure
DP 5 double product
HR 5 heart rate
IHD 5 ischemic heart disease
MI 5 myocardial infarction
OSAS 5 obstructive sleep apnea syndrome
REM 5 rapid eye movement
SaO2 5 oxygen saturation
VD 5 vessel disease
Table 1. Literature Review of OSAS and Night Ischemia
Author Journal Patients Results
De Olazabal et al. (9) Chest 1982 11 OSAS 1 IHD No AP nor MI during apnea




Koehler et al. (13) Klin Wocheschr 1991 20 OSAS 1 IHD, 10
OSAS without IHD
5/20 pts had 85 ischemic events;
REM predominance; occurred
toward end of apneas. Control:
1/10 had ischemia
Andreas et al. (10) Pneumologie 1991 15 OSAS without IHD No nocturnal Ischemia
Hillman D (3) Sleep 1993 16 OSAS 1 IHD Minimal nocturnal ischemia
Hanley et al. (8) Am J Cardiol 1993 23 OSAS without IHD 7/23 had nocturnal ischemia;
CPAP ameliorated ischemia
Ono et al. (14) Kokyo To Junken 1993 1 OSAS Pts, OXI 5 49%
AHI 5 50
Ischemia occurred at minimal
desaturation
Keyl et al. (11) Br Anaesth 1994 30 pre-CABG 10 pts had nocturnal ischemia; no
association between HR, OXI
and ischemia
Franklin et al. (6) Lancet 1995 10 nocturnal angina pectoris 9/10 had OSAS; CPAP
ameliorated ischemia
Scha¨fer et al. (7) Chest 1997 14 OSAS 1 IHD, 7 OSAS
without IHD
5/14 had ischemia during REM
and hypoxemia; control: 1/7
had ischemia
AHI 5 apnea hypopnea index; CPAP 5 continuous positive air pressure; HR 5 heart rate; IHD 5 ischemic heart disease; MI 5 myocardial infarction; OSAS 5 obstructive
sleep apnea syndrome; Pts 5 patients; REM 5 rapid eye movements.
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of 1 cm/s. In addition, two ECG Holter channels
(Dynacord-TM 420, DMS-Diagnostics Monitoring Sys-
tems, California) of a modified V5 left ventricular lead and
a modified atrial and right ventricular lead and blood
pressure (BP) measurements once every 30 min (Circadian
3 portable monitor) were carried out throughout the 24 h
period that included the sleep study. All three recorders:
polygraph, Holter and BP monitor, were time synchronized.
Bedtime was 23:00 to 06:00 (all patients were awakened at
06:00). Data was collected until 08:00 in order to evaluate
immediate post-sleep changes.
Data analysis. Sleep architecture was analyzed according
to Rechtschaffen and Kales’ criteria (15). The severity of
OSAS was determined by AHI which represents the num-
ber of apnea and hypopnea per hour of sleep and by oxygen
desaturation values: minimal value [oxygen saturation
(SaO2 min)] and percent sleep time that saturation was
below 90% (SaO2 , 90%). Obstructive apnea was sought
visually as an absence of airflow for at least 10 s in the
presence of continued respiratory efforts. Hypopnea was
defined as a reduction in the amplitude of respiratory effort
for $50% from the sleeping baseline. The diagnosis of
OSAS was based on a finding of at least an AHI of 10 in
combination with typical complaints such as excessive day-
time sleepiness, restless sleep or unexplained prolonged
fatigue. An episode of myocardial ischemia was defined as
flat or downsloping ST segment depression .1 mm from
baseline for $0.08 s after the J point, lasting for at least
1 min and separated from the next episode by at least 1 min.
Only one lead showing the largest number of ischemic
episodes was used for analysis. The Holter tapes were
analyzed without knowledge of the results of the sleep
study. Double product (DP) values were calculated based on
the 30 min BP values and heart rate data [DP 5 systolic BP
3 heart rate (HR)]. Heart rate was determined by the ECG
holter every minute.
Continuous positive air pressure treatment. Fifteen pa-
tients (nine had nocturnal ischemia at the first study) were
monitored under whole night CPAP treatment conducted
after one night of titration.
Statistical analysis. Two sample t tests, t test for paired
samples, Pearson product moment correlations and analysis
of variance (ANOVA) were used for data analysis.
RESULTS
Table 2 summarized the clinical data for patients with and
without IHD. Except for age, there were no significant
differences between the two groups.
Heart rate and blood pressure. Systolic BP during sleep
correlated with age (r 5 0.46, p 5 0.001) and with AHI
(r 5 0.39, p 5 0.004), whereas no significant association
was found between sleep BP and oxygen desaturation nor
with IHD severity. Night and day HR values increased with
the increase in AHI (r 5 0.58, p 5 0.001). Mean nocturnal
HR was 65.9 6 7.9 beats/min for mild OSAS (AHI # 20;
n 5 27) and 75.2 6 9.4 for the severe group (AHI . 40;
n 5 9, p 5 0.001). Heart rate did not correlate with oxygen
desaturation values. Double product values, which indicate
myocardial load, were also associated with AHI (r 5 0.62,
p 5 0.000).
Nocturnal ischemia. Ten patients had a total of 15 noc-
turnal ischemic events as defined above. Six of them had
also a total of six events during the morning hours (6:00 AM
to 8:00 AM). An additional five patients had only morning
ischemia (a total of five events). Thus the temporal distri-
bution of the ischemic events was as follows: four events (46
ischemic min) occurred until 02:00, eleven events (136 min)
during the rest of the night until wake up and eleven events
(148 ischemic min) occurred during the first 2 h after
waking up (Fig. 1). None of the patients in the control
group showed any ischemic event. Patients with nocturnal
ischemia were on the average 8 years older (age 67.8 6 7.1
vs. 59.7 6 7.9; p , 0.002), had worse sleep efficiency
(61.5% 6 16.2% vs. 80.5% 6 10.6%, p , 0.001), had more
severe IHD (Mets for ischemia at ergometry: 6.6 6 2.3 vs.
8.4 6 2.0; p , 0.02), had deeper oxygen desaturation
during sleep (SaO2 min: 79.3% 6 3.7% vs. 83.6% 6 7.5%;
p , 0.04), had higher nocturnal systolic BP (138.6 6
22.8 mm Hg vs. 126.8 6 14.9 mm Hg; p , 0.02) and had
a higher nocturnal maximal DP values (14,193 6 3,468 vs.
12,086 6 2,721; p , 0.02).
Interestingly, AHI did not differentiate between patients
with and without nocturnal ischemia. Across patients, DP
values and their components were maximal at the time of
ischemia compared with before (21 h) or after (11 h) the
ischemic period. For this analysis, the BP and HR values
measured at the time closest to the ischemic event were
considered as the ischemic DP values. Double product
increased from 8,319 6 2,486 (21 h) to 11,260 6 3,150
(p , 0.000) and decreased subsequently to 8,681 6 2,653
(11 h; p , 0.001). The corresponding values of HR were
62.9 6 10.2 (21 h), 76.3 6 13.6 (ischemic time; p ,
0.0001) and 67.1 6 10.8 (11, p , 0.0001). The values of
SaO2 min were 87.1% 6 5.3% (21 h), 86.5% 6 5.1% at the
Table 2. Clinical Data for Patients With and Without IHD
IHD 1 SAS SAS p
n 51 17
Age (yrs) 61.3 6 8.3 47.4 6 10.9 0.001
BMI 28.3 6 4.2 30.4 6 6.4 NS
Functional capacity 2.06 6 0.76 —
Mets for ischemia* 8.08 6 2.18 —
AHI 26.8 6 21.2 33.3 6 24.0 NS
SaO2 min 82.8 6 7.1 82.3 6 15.5 NS
SaO2 , 90% 5.1 6 7.9 7.9 6 13.6 NS
AHI 5 apnea hypopnea index; BMI 5 body mass index; SaO2 min 5 minimal
oxygen saturation; SaO2 , 90% 5 percent time that oxygen saturation was ,90%.
*Mets for ischemia during ergometry (Bruce-modified).
1746 Peled et al. JACC Vol. 34, No. 6, 1999
Nocturnal Ischemic Events in Patients With OSAS and IHD November 15, 1999:1744–9
time of ischemia NS (not significant) and 91.2% 6 2.5%
(11 h, p , 0.002), respectively. The deepest ST segment
deviation was at the rebreathing phase of the obstructive
apnea (Fig. 2). Likewise, this phase was also frequently
associated with the start of the ischemic event.
CPAP treatment. Fifteen patients were treated by nasal
CPAP of whom nine had nocturnal or morning ischemia
during the first study. Overall, CPAP treatment reduced the
number of ischemic events from 13 (78 min) to 6 (33 min;
p 5 0.01, Fig. 3). As expected, OSAS improved signifi-
cantly under CPAP (AHI: 35.1 6 20 vs. 10.1 6 5.7 p ,
0.001; SaO2 min: 78.6% 6 6.5% vs. 87.1% 6 5.1%, p ,
0.001). Likewise, HR (mean and maximum) and DP values
decreased significantly under CPAP (Table 3). However,
whenever nocturnal ischemia occurred under CPAP, DP
values during the ischemic events remained unchanged by
CPAP in comparison with pretreatment values (DP:
12,263 6 2,456 vs. 13,084 6 2,781, respectively, NS).
DISCUSSION
Twenty percent of our patients (10/51) who suffered from
IHD and OSAS had ST segment depression during sleep.
Moreover, six of them, as well as an additional five patients
also had ischemia during the first 2 h after waking up. We
should note, however, that patients were studied without
beta-blockers and nitrates which would contribute to the
high prevalence of ischemic events. Thus, a total of 15 out
Figure 1. Distribution of ischemic time across the sleep period
(23:00 to 06:00) and during the first 2 h after awakening. This is
based on data obtained from all patients who demonstrated
ischemia; p , 0.06 one-way ANOVA. ANOVA 5 analysis of
variance.
Figure 2. (A) ST segment depression at the rebreathing phases of the apneas. This 5-min Holter recording depicts alternating ECG
patterns of bradycardia-tachycardia typical of sleep apnea. Horizontal ST segment depressions of $1 mm were recorded at the tachycardia
(rebreathing) phase. (B) An enlarged segment of a tachycardia phase, starting at approximately 01:58:30 clearly demonstrating the ST
segment depression.
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of 51 patients, i.e., 29%, showed evidence of ischemia
during the study. Apart from age and IHD severity, oxygen
desaturation and DP values were the main factors that were
associated with nocturnal ischemic events. Thus, it can be
proposed that an increase in myocardial oxygen demand,
and a decrease in its supply, precipitates ischemia in patients
with an inappropriate coronary reserve. The control group
who had the same severity of OSAS but without any
evidence of IHD did not show any sign of ischemia during
sleep or during the day. Our results also demonstrate that
CPAP treatment significantly ameliorated the ischemic
changes during sleep although it did not entirely eliminate
them. Based on these results, and previous studies, it
appears that the main risk factor for cardiac ischemia during
sleep in OSAS is the presence of IHD (6,7,13,16–18).
The prevalence of ischemia found in our study population
was similar to that previously reported in similar groups of
patients. Koehler et al. (13) showed ischemia in 5 out of 20
patients (OSAS 1 IHD), mainly during REM sleep;
Scha¨fer et al. (7) showed that 5 out of 14 patients had
ischemia during REM sleep and hypoxemia. On the other
hand, Olazabal et al. (9) and Hillman (3), who examined
similar groups of patients, did not find any significant
ischemic changes. Since we did not have a control group of
matched IHD patients who were free from OSAS, based on
our study we cannot determine if the coexistence of OSAS
and IHD is associated with more nocturnal ischemic events
than IHD alone. However, the incidence of nocturnal
ischemia in IHD patients which is considered to be about
20% (19,20) is probably overestimated. Since the prevalence
of OSAS among unselected IHD patients is extremely high
(37% – 64%) (9,21,22), it is highly likely that patients with
a combination of OSAS and IHD were included in these
early studies.
The incidence of ischemia increased through the night
and peaked during the first hour after awakening (Fig. 1).
This is in agreement with previous findings (23–25), related
to late night and early morning increase in sympathetic
activity (26) and in platelet aggregability (27). Moreover,
the early morning increase in the relative amount of REM
sleep, which is associated with both sympathetic activation
and prolonged apneas and deeper desaturations, may also
trigger the occurrence of ischemic events at this time in
OSAS patients. However, in contrast with previous findings
(7,13), we did not find any significant association between
REM sleep and ischemia.
Continuous positive air pressure treatment. Treatment
with CPAP ameliorated ischemia throughout the night.
Some factors may explain this improvement: the decrease in
HR under CPAP (Table 3), the increase in oxygen satura-
tion and the decrease in AHI which is followed by a
decrease in the negative intrathoracic pressure, i.e. decrease
of myocardial wall stress (30). However, since monitoring
under CPAP was conducted after a single night of treat-
ment, the effects of a longer treatment period should be
investigated. The lack of improvement in the ischemic time
during the morning hours (6:00 AM to 8:00 AM) may be due
to a short period of treatment. Daytime improvement of
hypertension was achieved only by long-term CPAP treat-
ment (31).
Proposed mechanism. The changes in heart rate and DP
values before, during and after the ischemic episodes, and
the lack of similar changes in the level of oxygen saturation,
may suggest that the main cause of ischemia was the
increase in oxygen demand and not in its supply. Further-
more, the fact that the deepest ST segment depression
occurred at the rebreathing phase of the obstructive apnea,
which is characterized by marked tachycardia and sympa-
thetic surge (28,29), also points to the profound impact of
oxygen consumption underlying the ischemic event. Like-
Figure 3. Ischemic minutes before and during CPAP treatment (9
patients) (p , 0.01, paired t test). CPAP 5 continuous positive air
pressure.
Table 3. The Effects of CPAP on OSAS Severity and
Hemodynamic Variables
Measure Pre-CPAP CPAP p
OSAS Severity
AHI 35.1 6 20.0 10.1 6 5.7 0.001
SaO2 min 78.6 6 6.5 87.1 6 5.1 0.001
SaO2 , 90% 10.1 6 10.6 1.5 6 1.9 0.004
Apnea Dur (Max) 51.7 6 11.4 45.8 6 7.4 0.038
% REM 12.0 6 8.0 16.4 6 6.4 0.046
Hemodynamic Study
BP-SYS-sleep 135.7 6 21.7 133.1 6 19.7 NS
BP-DIA-sleep 79.6 6 13.0 78.9 6 11.2 NS
HR-sleep 70.4 6 9.0 64.5 6 11.5 0.006
HR-max-sleep 91.9 6 11.5 82.8 6 10.9 0.005
DP-Avg-sleep 9,589 6 2,200 8,700 6 2,592 0.004
DP-max-sleep 14,137 6 2,827 12,083 6 2,933 0.001
DP-mor (06–08) 11,817 6 2,164 10,032 6 2,440 0.001
DP-mor (07–08) 12,013 6 2,507 10,893 6 2,075 0.080
AHI 5 apnea hypopnea index; BP 5 blood pressure; CPAP 5 continuous positive
air pressure; DIA 5 diastolic; DP 5 double product; Dur 5 duration (seconds);
mor 5 morning; OSAS 5 obstructive sleep apnea syndrome; SaO2 min 5 minimal
oxygen saturation level; SaO2 , 90% 5 percent time of oxygen saturation ,90%;
SYS 5 systolic.
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wise, the increase in myocardial wall tension during the
obstructive apnea (30) and the elevation of BP and HR
during the rebreathing phase (32) reduces the oxygen supply
to the myocardium, due to shortening of the diastolic phase
and also due to stronger intramural squeezing forces com-
bined with increased oxygen demand. Therefore, at this
phase, maximal oxygen consumption coexists with a reduced
supply, a condition which could trigger the ischemic events.
The analysis of the effects of CPAP on the ischemic
events also supports the above conclusion. Although CPAP
treatment significantly ameliorated nocturnal ischemia, it
did not eliminate ischemia entirely. The ischemic events
that remained under CPAP treatment were associated with
DP values that were very similar to the corresponding
pretreatment values, although overall DP and SaO2 , 90%
improved under CPAP (Table 3). These findings may also
support the suggestion that in OSAS patients with inade-
quate coronary reserve, the main cause of nocturnal ischemia
is the increased myocardial oxygen consumption rather than
the reduction in oxygen supply. Thus, in order to minimize
nocturnal ischemic events in these patients, a combination
of CPAP treatment and medical therapy to control HR and
BP increases is warranted.
In summary, OSAS may exacerbate ischemia during sleep
when inappropriate coronary reserve coexists (and remains
untreated). We suggest that the increase in myocardial
oxygen consumption is the main cause of nocturnal ischemia
although oxygen supply decreases during OSAS as well.
Reprint requests and correspondence: P. Lavie, Sleep Labora-
tory, Gutwirth Building, Technion-Israel Institute of Technology,
Haifa, Israel 32000. E-mail: plavie@techunix technion.ac.il.
REFERENCES
1. Koskenvuo M, Kaprio J, Partinen M, Langinvainio H, Sarna S,
Heikkila K. Snoring as a risk factor for hypertension and angina
pectoris. Lancet 1985;1:893–5.
2. Koskenvuo M, Kaprio J, Telvakivi T, Partinen M, Heikkila K, Sarna
S. Snoring as a risk factor for ischemic heart disease and stroke in men.
Brit Med J 1987;294:16–9.
3. Hillman DR. Sleep apnea and myocardial infarction. Sleep 1993;16:
S23–4.
4. Fletcher EC, Lesske J, Behm R, Miller CC, Stauss H, Unger T.
Carotid chemoreceptors, systemic blood pressure and chronic episodic
hypoxia mimicking sleep apnea. J Appl Physiol 1992;72:1978–84.
5. Van Den Aardweg JG, Karemaker JM. Repetitive apnea induced
periodic hypertension in normal subjects through hypoxia. J Appl
Physiol 1992;72:821–7.
6. Franklin KA, Nisson JB, Sahlin C, Na¨slund U. Sleep apnea and
nocturnal angina. Lancet 1995;345:1085–7.
7. Scha¨fer H, Koehler U, Ploch T, Peter JH. Sleep related myocardial
ischemia and sleep structure in patients with obstructive sleep apnea
and coronary heart disease. Chest 1997;111:387–93.
8. Hanly P, Sasson Z, Zuberi N, Lunn K. ST segment depression during
sleep in obstructive sleep apnea. Am J Cardiol 1993;71:1341–5.
9. De Olazabal JR, Miller MJ, Cook WR, Mithhoefer JC. Disordered
breathing and hypoxia during sleep in coronary artery disease. Chest
1982;82:548–52.
10. Andreas S, Hajak G, Natt P, Auge D, Ru¨ther E, Kreuzer H. ST
segment changes and arrhythmias in obstructive sleep anpea. Pneu-
mologie 1991;45:720–4.
11. Keyl C, Lamberger P, Rodig G, Dambacher M, Frey A. Hypoxemia
and myocardial ischemia on the night before coronary bypass surgery.
Br J Anaesth 1994;73:157–61.
12. Quyyumi AA, Efthimiou J, Quyyumi A, Mockus LJ, Spiro SG, Fox
KM. Nocturnal angina: precipitating factors in patients with coronary
artery disease and those with variant angina. Br Heart J 1986;56:346–
52.
13. Koehler U, Dubler H, Glaremin T, et al. Nocturnal myocardial
ischemia and cardiac arrhythmia in patients with sleep apnea with and
without coronary heart disease. Klin Wochenschr 1991;69:474–82.
14. Ono S, Joshita Y, Morooka S, et al. ST-T changes associated with
severe hypoxia in a case of obstructive sleep apnea syndrome. Kokyu
To Junkan 1993;41:487–91.
15. Rechtschaffen A, Kales A, eds. A Manual of Standardized Terminol-
ogy, Techniques and Scoring System for Sleep Stages of Human
Subjects. Los Angeles: UCLA, Brain Information Service/Brain Re-
search, University of California, 1968.
16. Goldman MD, Reeder MK, Muir AD, et al. Repetitive nocturnal
arterial oxygen desaturation and silent myocardial ischemia in patients
presenting for vascular surgery. J Am Geriat Soc 1993;41:703–9.
17. Abinader EG, Peled N, Sharif D, Lavie P. ST segment depression
during obstructive sleep apnea. Am J Cardiol 1994;73:727.
18. Philip P, Guilleminault C. ST segment abnormality, angina during
sleep and obstructive sleep apnea. Sleep 1993;16:558–9.
19. Barry J, Campbell S, Yeung AC, Raby KE, Selwyn AP. Waking and
rising at night as a trigger of myocardial ischemia. Am J Cardiol
1991;67:1067–72.
20. Lavery CE, Mittleman MA, Cohen MC, Muller JE, Verrier RL.
Nonuniform nighttime distribution of acute cardiac events: a possible
effect of sleep states. Circulation 1997;96:3321–7.
21. Mooe T, Rabben T, Wiklund U, Franklin KA, Eriksson P. Sleep-
disordered breathing in men with coronary artery disease. Chest
1996;109:659–63.
22. Andreas S, Schulz R, Werner GS, Kreuzer H. Prevalence of obstruc-
tive sleep apnea in patients with coronary artery disease. Coron Artery
Dis 1996;7:541–5.
23. Marsh EE, Biller J, Adams HP, et al. Circadian variation in onset of
acute ischemic stroke. Arch Neurol 1990;47:1178–80.
24. Haumsmann D, Nikutta P, Trappe HJ, Werner GD, Wenzlaff P,
Lichtlen PR. Circadian distribution of the characteristics of ischemic
episodes in patients with stable coronary artery disease. Am J Cardiol
1990;66:668–72.
25. Schlant RC. Circadian variation in myocardial ischemia. JAMA
1991;265:386–90.
26. Virend KS, Marrk ED, Allyn LM, Francois MA. Sympathetic-nerve
activity during sleep in normal subjects. N Engl J Med 1993;328:
303–7.
27. Jovicic A, Mandic S. Circadian variation of platelet aggregability and
fibrinolytic activity in healthy subjects. Thrombosis Res 1991;62:65–
74.
28. Hedner J, Ejnell H, Sellgren J, Hedner T, Wallin G. Is high and
fluctuating muscle nerve sympathetic activity in sleep apnea syndrome
of pathogenetic importance for the development of hypertension?
J Hypertens 1988;6 Suppl 4:S529–31.
29. Shimizu T, Takahashi Y, Kogawa S. Muscle sympathetic nerve activity
during apneic episodes in patients with obstructive sleep apnea
syndrome. Electroencephal Clin Neurophysiol 1994;93:345–52.
30. Parish JM, Shepard JW. Cardiovascular effects of sleep apnea disor-
ders. Chest 1990;97:1220–6.
31. Fletcher EC. Can the treatment of sleep apnea syndrome prevent the
cardiovascular consequences. Sleep 1996;19:S67–70.
32. Van den Aardweg JG, Karemaker JM. Respiratory variability and
associated cardiovascular changes in adults at rest. Clin Phys 1991;11:
95–118.
1749JACC Vol. 34, No. 6, 1999 Peled et al.
November 15, 1999:1744–9 Nocturnal Ischemic Events in Patients With OSAS and IHD
